AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2013
Dec 4, 2013
29821_dirs_2013-12-04_e512beae-08d0-4d68-97e4-4dcd1c77a2f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-11-08
Reporting Person: Mirviss Jeffrey B. (SVP&Pres, Periph Intervent)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-08 | Common Stock | M | 20000.0000 | $6.3100 | Acquired | 85190.0000 | Direct |
| 2013-11-08 | Common Stock | S | 20000.0000 | $11.8701 | Disposed | 65190.0000 | Direct |
| 2013-11-11 | Common Stock | S | 6000.0000 | $12.0214 | Disposed | 59190.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-08 | Stock Option (Right to Buy) | $6.3100 | M | 20000.0000 | Disposed | 2020-10-25 | Common Stock (20000.0000) | Direct |
Footnotes
F1: This amended Form 4 is being filed to report the stock option exercise that was omitted from the reporting person's Form 4 filed on November 12, 2013 and to correct the number of securities beneficially owned by the reporting person following the sale transactions on each of November 8, 2013 and November 11, 2013 as previously reported in the Form 4 filed on November 12, 2013 (see also Footnote 2).
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Sale transaction was previously reported on the reporting person's Form 4 filed on November 12, 2013.
F4: Represents the weighted average sale price. These shares were sold in multiple transactions at $11.8700 and $11.8710. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: Represents the weighted average sale price. These shares were sold in multiple transactions at $12.0202 and $12.0220. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: Grant to reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on October 25, 2011, the first anniversary of the date of grant.